Pre-operative Treatment for Patients With Untreated Pancreatic Cancer
Status:
Active, not recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the combination of paclitaxel protein bound,
gemcitabine, cisplatin, paricalcitol are effective in individuals with resectable and
unresectable pancreatic cancer.